Logo

American Heart Association

  2
  0


Final ID: Sa2068

Longer AF Diagnosis-to-Ablation Time is Associated with AF Inducibility Post-Pulmonary Vein Isolation

Abstract Body (Do not enter title and authors here): Background:
Post-ablation atrial fibrillation (AF) inducibility has been associated with AF recurrence and is often used as an endpoint for Pulmonary Vein Isolation (PVI). Little is known regarding factors affecting inducibility after PVI, as AF inducibility is common even after PV isolation. Prolonged episodes of untreated AF can result in remodeling of the atrium and the formation of new arrhythmogenic substrate, which may make treatment of AF more challenging. We hypothesized that longer diagnosis-to-ablation time (DAT) is associated with higher rates of post-PVI AF inducibility.

Objective:
To evaluate DATs in cases of inducible vs. non-inducible AF post ablation.

Methods:
A single-center, retrospective analysis of 168 consecutive patients who underwent 1st time PVI between 1/1/2022 and 12/01/2023 was performed. Following PVI, inducibility of AF was tested by programmed stimulation using decremental pacing in 50ms windows for 10 seconds each (from 400 ms down to 200 ms or until loss of 1:1 atrial capture). Results were categorized by type of rhythm induced (non-inducible, AF) and duration (sustained, non-sustained). DAT was obtained from review of the medical records. Descriptive statistics were used to compare demographics and AF type, and parametric and non-parametric tests were used for analysis of the diagnosis-to-ablation window and its relationship to inducibility.

Results:
There was no difference in demographic data or AF type between the two groups. 85 patients (50.6%), had no inducible AF. 83 out of 168 cases (49.4%) had inducible sustained AF. Overall DATs ranged from 0 to 40 years. DAT was significantly higher in the inducible vs. non-inducible groups (3.810 vs. 2.906 years, p=0.023).

Conclusion:
Longer DAT is associated with AF inducibility post-PVI despite successful ablation. This association may reflect the increased persistence of AF as it progresses over time. Future studies are needed to evaluate the clinical implications of DAT times.
  • Bailey, Grace  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Friehling, Mati  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Duan, Chaojing  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Liu, Emerson  ( ALLEGHENY GENERAL HOSPITAL , Pittsburgh , Pennsylvania , United States )
  • Phalunas, Caitlin  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Lathia, Minesh  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Belden, Elizabeth  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Belden, William  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Thosani, Amit  ( ALLEGHENY GENERAL HOSPITAL , Pittsburgh , Pennsylvania , United States )
  • Silverstein, Joshua  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Shaw, George  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Cherian, Tharian  ( Allegheny Health Network , Pittsburgh , Pennsylvania , United States )
  • Author Disclosures:
    Grace Bailey: DO NOT have relevant financial relationships | Mati Friehling: DO NOT have relevant financial relationships | Chaojing Duan: DO NOT have relevant financial relationships | Emerson Liu: No Answer | Caitlin Phalunas: DO NOT have relevant financial relationships | Minesh Lathia: No Answer | Elizabeth Belden: DO NOT have relevant financial relationships | William Belden: No Answer | Amit Thosani: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Johnson & Johnson; Physician Education :Active (exists now) ; Other (please indicate in the box next to the company name):Abbott; Physician Education :Active (exists now) ; Other (please indicate in the box next to the company name):Medtronic; Physician Education :Active (exists now) | Joshua Silverstein: DO have relevant financial relationships ; Consultant:Biosense Webster:Active (exists now) ; Speaker:Impulse Dynamics:Active (exists now) ; Consultant:Medtronic:Active (exists now) | George Shaw: DO NOT have relevant financial relationships | Tharian Cherian: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Atrial Fibrillation Ablation: Heart Failure, Myopathies and More

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
Characterization of the Near-Field Bipolar Voltage Substrate Using a Novel Automated Peak Frequency Algorithm in Patients Undergoing Catheter Ablation of Postinfarction Ventricular Tachycardia

Nimmagadda Manojna, Saliba Walid, Bhargava Mandeep, Wazni Oussama, Nakagawa Hiroshi, Hussein Ayman, Santangeli Pasquale, Korzon Monica, Younis Arwa, Lee Justin, Higuchi Koji, Sroubek Jakub, Chung Roy, Kanj Mohamed, Nakhla Shady

12,13-diHOME Attenuates Pro-Arrhythmic Effect of High-Fat Diet

Buck Benjamin, Baer Lisa, Deschenes Isabelle, Chinthalapudi Krishna, Gallego-perez Daniel, Stanford Kristin, Hund Thomas, Areiza Natalia, Xu Xianyao, Elliott Austin, Wan Xiaoping, Nassal Drew, Lane Cemantha, Nirengi Shinsuke, James Natasha Maria

More abstracts from these authors:
Length of WACA line Affects 1st Pass Success rates in PVI

Belden Elizabeth, Cherian Tharian, Duan Chaojing, Liu Emerson, Phalunas Caitlin, Bailey Grace, Lathia Minesh, Thosani Amit, Belden William, Silverstein Joshua, Shaw George, Friehling Mati

Management of Atrial Flutter (AFL) Using Intrinsic Antitachycardia Pacing (iATP) Protocol

Silverstein Joshua, Belden Elizabeth, Lathia Minesh, Bailey Grace, Thosani Amit, Gupta Manasvi, Duan Chaojing, Phalunas Caitlin, Shaw George, Liu Emerson, Cherian Tharian, Belden William, Friehling Mati

You have to be authorized to contact abstract author. Please, Login
Not Available